Skinoren cream 20% 30g

Skinoren cream Composition:
active ingredient: micronized azelaic acid; 1 g of cream contains 0.2 g of micronized azelaic acid; excipients: benzoic acid (E 210), stearyl macrogol glycerides, Kutina CBS (a mixture of mono-diglycerides, fatty acids, triglycerides and wax ester), cetearyl loctanoate, propylene glycol, glycerin 85%, purified water.

Pharmacotherapeutic group:
Local remedies for acne treatment. ATX code D10A X03.

Indications:
Treatment of acne (blackheads), characterized by the presence of comedones, papules, pustules and small nodules.

Dosage and administration:
For skin application. Apply Skinoren 2 times a day (morning and evening) to the affected areas of the skin and gently rub in with massage movements. Approximately 2.5 cm of cream is sufficient for the entire surface of the face. Before applying Skinoren cream, the skin should be thoroughly washed with water and dried. You can also use a mild cosmetic product to cleanse the skin.

Regular use of Skinoren cream during the entire course of treatment is important. The duration of the course of treatment may vary depending on the individual course of the disease and is determined by the degree of its severity. To achieve optimal results, it is recommended to use Skinoren continuously for several months. There is clinical experience with continuous use of the drug for up to 1 year. In patients with acne, a noticeable improvement is usually observed after 4 weeks. In case of excessive skin irritation (see section “Adverse reactions”), reduce the amount of cream for application or the frequency of application of Skinoren cream to 1 time per day until the irritation disappears. If necessary, therapy can be temporarily interrupted for several days. After a short period of treatment without noticeable results, a second medical evaluation is necessary.

Elderly patients.
Special studies of the use of the drug in patients over the age of 65 years have not been conducted. Patients with impaired liver function. Special studies of the use of the drug in patients with impaired liver function have not been conducted. Patients with impaired renal function. Special studies of the use of the drug in patients with impaired renal function have not been conducted.

Produced in Italy